Intensive non-sympathetic activating vasodilatory treatment in hypertensive patients with microvascular angina pectoris

Trial Profile

Intensive non-sympathetic activating vasodilatory treatment in hypertensive patients with microvascular angina pectoris

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2012

At a glance

  • Drugs Diltiazem; Doxazosin; Isosorbide mononitrate; Lercanidipine; Metoprolol; Nicorandil; Valsartan
  • Indications Angina pectoris; Hypertension
  • Focus Therapeutic Use
  • Acronyms Vasointense
  • Most Recent Events

    • 12 May 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 12 May 2009 Planned number of patients changed from 100 to 10 as reported by ClinicalTrials.gov.
    • 11 Feb 2008 The expected completion date for this trial is now 1 Dec 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top